NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 1,618.00
+42.00 (2.66%)
Nov 2, 2026, 3:30 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 159.97 billion as of October 30, 2026. It is the 24,038th most valuable company in the world and the 964th biggest in South Korea. Its market cap has decreased by 43.62% in one year.
Market Cap
159.97B
Enterprise Value
123.97B
Revenue
1.76B
Global Rank
Country Rank
#964 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 159.97B, a decrease of -97.82%. That is a compound annual growth rate of -49.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 159.97B | -60.58% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SillaJen | 279.88B |
| Genomictree | 244.71B |
| HLB Therapeutics | 219.91B |
| GC Genome | 215.22B |
| Bioneer | 175.77B |
| Helixmith | 170.37B |
| GC Cell | 151.77B |
| Anterogen.Co.,Ltd. | 133.68B |